Fonar Corporation (FONR) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $18.57
• Market Cap: $92.74M
• P/E Ratio: 13.27
• EPS: $1.11
• 52-Week High: $18.86
• 52-Week Low: $12.00

Market Sentiment

Fonar Corporation currently has a Neutral sentiment score of -0.08.

About Fonar Corporation

Fonar Corporation (FONR) is a prominent player in the medical imaging industry, renowned for its cutting-edge advancements in Magnetic Resonance Imaging (MRI) technology aimed at enhancing disease detection and diagnosis. Headquartered in Melville, New York, Fonar is committed to innovation through ongoing clinical studies that seek to refine and elevate MRI performance, thereby improving patient care. With a strategic focus on delivering high-resolution imaging solutions, the company is pois...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fonar Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FONR pay dividends?

Fonar Corporation (FONR) does not currently pay a regular dividend.

What is FONR's P/E ratio?

Fonar Corporation has a price-to-earnings (P/E) ratio of 13.27.

What is FONR's market cap?

Fonar Corporation (FONR) has a market capitalization of $92.74M with a current stock price of $18.57.